Search Results - Berhani, O

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    74 Targeting the Immune System to Cancer

    74 Targeting the Immune System to Cancer by Levitzki, A, Shir, A, Berhani, O, Langut, Y, Zigler, M, Ben-Ezri, E, Pesach, N, Klein, S

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Gene Editing/Gene Therapies: GDA-201: PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF CRYOPRESERVED NICOTINAMIDE-EXPANDED ALLOGENEIC NATURAL KILLER CELLS DEMONSTRATE AN ACTIVATED AND NON-EXHAUSTED PHENOTYPE

    Gene Editing/Gene Therapies: GDA-201: PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF CRYOPRESERVED NICOTINAMIDE-EXPANDED ALLOGENEIC NATURAL KILLER CELLS DEMONSTRATE AN ACTIVATED AND... by Solomon, I., Berhani-Zipori, O., Gamliel, M., Seed, S., Yeffet, A., Meirow, Y., Arbib, E., Yoffe-Mizrahi, Y., Simantov, R., Geffen, Y.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    1225 - Gene Editing/Gene Therapies: GDA-501 HER-2 CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELLS: DUAL CYTOTOXICITY IN SOLID TUMORS MEDIATED VIA HER2 AND TRAIL

    1225 - Gene Editing/Gene Therapies: GDA-501 HER-2 CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELLS: DUAL CYTOTOXICITY IN SOLID TUMORS MEDIATED VIA HER2 AND TRAIL by Rifman, J., Berhani-Zipori, O., Yackoubov, D., Cohen, S., Brycman, N., Hailu, A., Edri, A., Simantov, R., Pato, A., Geffen, Y.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Gene Editing/Gene Therapies: GDA-501 HER-2 CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELLS: DUAL CYTOTOXICITY IN SOLID TUMORS MEDIATED VIA HER2 AND TRAIL

    Gene Editing/Gene Therapies: GDA-501 HER-2 CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELLS: DUAL CYTOTOXICITY IN SOLID TUMORS MEDIATED VIA HER2 AND TRAIL by Rifman, J., Berhani-Zipori, O., Yackoubov, D., Cohen, S., Brycman, N., Hailu, A., Edri, A., Simantov, R., Pato, A., Geffen, Y.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    36 - Gene Editing/Gene Therapies: GDA-201: PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF CRYOPRESERVED NICOTINAMIDE-EXPANDED ALLOGENEIC NATURAL KILLER CELLS DEMONSTRATE AN ACTIVATED AND NON-EXHAUSTED PHENOTYPE

    36 - Gene Editing/Gene Therapies: GDA-201: PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF CRYOPRESERVED NICOTINAMIDE-EXPANDED ALLOGENEIC NATURAL KILLER CELLS DEMONSTRATE AN ACTIVATE... by Solomon, I., Berhani-Zipori, O., Gamliel, M., Seed, S., Yeffet, A., Meirow, Y., Arbib, E., Yoffe-Mizrahi, Y., Simantov, R., Geffen, Y.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Immunotherapy: GDA-301: ENGINEERED NAM-NK CELLS VIA CISH KNOCKOUT AND MEMBRANE-BOUND IL-15 EXPRESSION INCREASES CYTOTOXICITY AGAINST MALIGNANCIES

    Immunotherapy: GDA-301: ENGINEERED NAM-NK CELLS VIA CISH KNOCKOUT AND MEMBRANE-BOUND IL-15 EXPRESSION INCREASES CYTOTOXICITY AGAINST MALIGNANCIES by Rifman, J., Haim, N. Ben, Cohen, S., Brycman, N., Hailu, A., Berhani-Zipori, O., Edri, A., Yackoubov, D., Simantov, R., Hendel, A., Pato, A., Geffen, Y.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Immunotherapy: GDA-601: NAM-NK CELLS WITH CD38 KNOCKOUT EXPRESSES ENHANCED CD38 CHIMERIC ANTIGEN RECEPTOR AND TARGETS MULTIPLE MYELOMA CELLS WITH INCREASED CYTOTOXICITY

    Immunotherapy: GDA-601: NAM-NK CELLS WITH CD38 KNOCKOUT EXPRESSES ENHANCED CD38 CHIMERIC ANTIGEN RECEPTOR AND TARGETS MULTIPLE MYELOMA CELLS WITH INCREASED CYTOTOXICITY by Edri, A., Hailu, A., Haim, N. Ben, Brycman, N., Berhani-Zipori, O., Rifman, J., Cohen, S., Yackoubov, D., Simantov, R., Hendel, A., Pato, A., Geffen, Y.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: